Clinical trial

Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

NCT07076914

Study summary

ClinicalTrials.gov

Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Experimental (Health Canada Approved Proton Pump Inhibitors) Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-02

PhasePHASE2

Conditions

Primary Lung Cancerunresolved

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Interventions

Experimental (Health Canada Approved Proton Pump Inhibitors)DRUG

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07076914 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.